Compare Stocks: HIMS, TEM, and BSX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSX Boston Scientific	$47.85 +1.9%	$46.90	$42.20 ▼ $109.50	$69.27B	0.57	18.84 million shs	15.50 million shs
HIMS Hims & Hers Health	$27.66 -0.6%	$31.67	$13.74 ▼ $65.30	$6.47B	2.42	12.75 million shs	7.14 million shs
TEM Tempus AI	$64.62 -0.1%	$55.77	$40.77 ▼ $104.32	$11.66B	3.72	7.82 million shs	4.56 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSX Boston Scientific	0.00%	+2.20%	-2.72%	-1.66%	-55.44%
HIMS Hims & Hers Health	0.00%	-4.22%	-6.69%	+5.36%	-37.85%
TEM Tempus AI	0.00%	+0.91%	+40.11%	+39.18%	-15.30%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSX Boston Scientific	$47.85 +1.9%	$46.90	$42.20 ▼ $109.50	$69.27B	0.57	18.84 million shs	15.50 million shs
HIMS Hims & Hers Health	$27.66 -0.6%	$31.67	$13.74 ▼ $65.30	$6.47B	2.42	12.75 million shs	7.14 million shs
TEM Tempus AI	$64.62 -0.1%	$55.77	$40.77 ▼ $104.32	$11.66B	3.72	7.82 million shs	4.56 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSX Boston Scientific	0.00%	+2.20%	-2.72%	-1.66%	-55.44%
HIMS Hims & Hers Health	0.00%	-4.22%	-6.69%	+5.36%	-37.85%
TEM Tempus AI	0.00%	+0.91%	+40.11%	+39.18%	-15.30%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BSX Boston Scientific	2.71	Moderate Buy	$71.62	49.67% Upside
HIMS Hims & Hers Health	2.19	Hold	$32.50	17.50% Upside
TEM Tempus AI	2.50	Moderate Buy	$68.93	6.67% Upside

Current Analyst Ratings Breakdown

Latest HIMS, TEM, and BSX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/2/2026	TEM Tempus AI	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$80.00
9/2/2026	TEM Tempus AI	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$80.00
9/1/2026	TEM Tempus AI	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$56.00 ➝ $76.00
8/27/2026	TEM Tempus AI	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/25/2026	BSX Boston Scientific	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$56.00
8/24/2026	HIMS Hims & Hers Health	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$27.00 ➝ $32.00
8/21/2026	HIMS Hims & Hers Health	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$39.00 ➝ $35.00
8/20/2026	TEM Tempus AI	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$70.00 ➝ $80.00
8/12/2026	TEM Tempus AI	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/11/2026	HIMS Hims & Hers Health	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$25.00 ➝ $26.00
8/11/2026	HIMS Hims & Hers Health	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$25.00 ➝ $30.00

(Data available from 9/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BSX Boston Scientific	$20.07B	3.45	$4.04 per share	11.85	$17.37 per share	2.75
HIMS Hims & Hers Health	$2.35B	2.75	$0.84 per share	33.11	$1.39 per share	19.90
TEM Tempus AI	$1.43B	8.14	N/A	N/A	$2.47 per share	26.16

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BSX Boston Scientific	$2.90B	$2.47	19.37	13.99	1.10	17.50%	19.28%	10.89%	10/28/2026 (Estimated)
HIMS Hims & Hers Health	$128.37M	-$0.63	N/A	55.32	N/A	-5.51%	-6.51%	-1.20%	11/9/2026 (Estimated)
TEM Tempus AI	-$245.03M	-$1.44	N/A	N/A	N/A	-17.77%	-50.28%	-10.33%	11/3/2026 (Estimated)

Latest HIMS, TEM, and BSX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/10/2026	Q2 2026	HIMS Hims & Hers Health	-$0.0498	-$0.37	-$0.3202	-$0.37	$698.90 million	$753.21 million
7/30/2026	Q2 2026	TEM Tempus AI	-$0.1428	-$0.04	+$0.1028	$0.03	$379.69 million	$382.49 million
7/29/2026	Q2 2026	BSX Boston Scientific	$0.83	$0.86	+$0.03	$0.61	$5.38 billion	$5.44 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BSX Boston Scientific	N/A	N/A	N/A	N/A	N/A
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
TEM Tempus AI	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BSX Boston Scientific	0.43	1.24	0.74
HIMS Hims & Hers Health	4.21	0.93	0.87
TEM Tempus AI	3.06	3.30	3.16

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BSX Boston Scientific	89.07%
HIMS Hims & Hers Health	63.52%
TEM Tempus AI	24.22%

Insider Ownership

Company	Insider Ownership
BSX Boston Scientific	0.34%
HIMS Hims & Hers Health	11.76%
TEM Tempus AI	24.26%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BSX Boston Scientific	59,000	1.45 billion	1.44 billion	Optionable
HIMS Hims & Hers Health	2,442	233.31 million	205.88 million	Optionable
TEM Tempus AI	3,800	180.44 million	136.66 million	N/A

HIMS, TEM, and BSX Headlines

Recent News About These Companies

Wellington Management Group LLP Sells 123,748 Shares of Tempus AI, Inc. $TEM

1 hour ago | marketbeat.com

Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

September 4 at 12:46 PM | rutlandherald.comR

Artificial Intelligence Stocks Worth Watching - September 1st

September 4 at 3:03 AM | americanbankingnews.com

Cantor Fitzgerald Begins Coverage on Tempus AI (NASDAQ:TEM)

September 4 at 1:44 AM | americanbankingnews.com

Tempus AI Got an $80 Target and 28% Upside Call. Is Wall Street Underestimating Its Healthcare Data Moat?

September 2, 2026 | insidermonkey.com

Tempus AI's data business is priced like a vendor, not a platform, analyst says

September 2, 2026 | msn.com

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Assembly Biosciences (ASMB)

September 2, 2026 | theglobeandmail.com

Tempus AI gains as Cantor issues new overweight on data and applications segment

September 2, 2026 | msn.com

Why Moderna's Cancer Vaccine Matters to Investors

September 2, 2026 | etftrends.comE

Artificial Intelligence Stocks To Watch Today - September 2nd

September 2, 2026 | marketbeat.com

Piper Sandler Upgrades Tempus AI to Overweight From Neutral, Adjusts PT to $76 From $56

September 2, 2026 | marketscreener.comM

Tempus AI (NASDAQ:TEM) Coverage Initiated by Analysts at Cantor Fitzgerald

September 2, 2026 | marketbeat.com

Tempus AI (NASDAQ:TEM) Director Nadja West Sells 3,000 Shares

September 2, 2026 | insidertrades.com

Nadja West Sells 3,000 Shares of Tempus AI (NASDAQ:TEM) Stock

September 1, 2026 | marketbeat.com

Piper Sandler Boosts Tempus AI (TEM) Stock Rating to Overweight with $76 Target

September 1, 2026 | blockonomi.com

Tempus AI upgraded at Piper Sandler on growth drivers

September 1, 2026 | msn.com

Tempus AI (NASDAQ:TEM) Shares Gap Up - Should You Buy?

September 1, 2026 | marketbeat.com

Artificial Intelligence Stocks To Watch Today - August 29th

September 1, 2026 | americanbankingnews.com

46,411 Shares in Tempus AI, Inc. $TEM Bought by Headlands Technologies LLC

August 31, 2026 | marketbeat.com

Artificial Intelligence Stocks To Consider - August 30th

August 30, 2026 | marketbeat.com

Tempus AI (NASDAQ:TEM) CEO Eric Lefkofsky Sells 238,152 Shares of Stock

August 28, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

HIMS, TEM, and BSX Company Descriptions

Boston Scientific NYSE:BSX

$47.85 +0.90 (+1.92%)

As of 09/4/2026 03:58 PM Eastern

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Hims & Hers Health NYSE:HIMS

$27.66 -0.16 (-0.58%)

As of 09/4/2026 03:58 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Tempus AI NASDAQ:TEM

$64.62 -0.04 (-0.06%)

As of 09/4/2026 04:00 PM Eastern

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HIMS, TEM, and BSX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HIMS, TEM, and BSX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HIMS, TEM, and BSX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HIMS, TEM, and BSX Company Descriptions

Boston Scientific NYSE:BSX

Hims & Hers Health NYSE:HIMS

Tempus AI NASDAQ:TEM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HIMS, TEM, and BSX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HIMS, TEM, and BSX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HIMS, TEM, and BSX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HIMS, TEM, and BSX Company Descriptions

Boston Scientific NYSE:BSX

Hims & Hers Health NYSE:HIMS

Tempus AI NASDAQ:TEM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools